Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trulieve Cannabis (TCNNF) EBIT Margin (2020 - 2025)

Trulieve Cannabis has reported EBIT Margin over the past 6 years, most recently at 5.22% for Q4 2025.

  • Quarterly results put EBIT Margin at 5.22% for Q4 2025, up 478.0% from a year ago — trailing twelve months through Dec 2025 was 12.15% (up 391.0% YoY), and the annual figure for FY2025 was 12.15%, up 391.0%.
  • EBIT Margin for Q4 2025 was 5.22% at Trulieve Cannabis, down from 14.66% in the prior quarter.
  • Over the last five years, EBIT Margin for TCNNF hit a ceiling of 37.44% in Q1 2021 and a floor of 103.37% in Q2 2023.
  • Median EBIT Margin over the past 5 years was 9.67% (2022), compared with a mean of 5.8%.
  • Biggest five-year swings in EBIT Margin: tumbled -11658bps in 2023 and later soared 11977bps in 2024.
  • Trulieve Cannabis' EBIT Margin stood at 3.71% in 2021, then soared by 147bps to 1.74% in 2022, then surged by 483bps to 10.17% in 2023, then plummeted by -96bps to 0.43% in 2024, then soared by 1101bps to 5.22% in 2025.
  • The last three reported values for EBIT Margin were 5.22% (Q4 2025), 14.66% (Q3 2025), and 17.42% (Q2 2025) per Business Quant data.